Current Report Filing (8-k)
04 Fevereiro 2019 - 11:32AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d)
OF
THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): January 29, 2019
Health
Insurance Innovations, Inc.
(Exact
name of registrant as specified in its charter)
Delaware
|
|
001-35811
|
|
46-1282634
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification
No.)
|
15438
N. Florida Avenue, Suite 201
Tampa,
Florida
|
|
33613
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (813) 397-1187
Not
Applicable
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[ ]
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
[ ]
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[ ]
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR
§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging
growth company [ ]
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ ]
On
January 29, 2019, Health Insurance Innovations, Inc. (the “Company”) was notified that at least 25 participating jurisdictions
have executed the Company’s previously disclosed Regulatory Settlement Agreement (the “RSA”) as of January 28,
2019, and therefore the RSA became finally effective as of January 28, 2019.
The
RSA, which was described in the Company’s Form 8-K filed on December 13, 2018, was entered into by the Company, together
with its subsidiary Health Plan Intermediaries Holdings, LLC, with the lead state regulators in the Company’s previously
disclosed multistate market conduct examination (the “MCE”). As disclosed in such prior Form 8-K, the provisions of
the RSA were subject to the execution of the RSA by a total of at least 25 of the participating jurisdictions in the MCE, and
on the date on which a total of 25 participating jurisdictions have executed the RSA, the RSA would become finally effective.
As stated in the RSA, any participating jurisdictions that have not adopted the RSA as of January 28, 2019 will continue to have
until March 12, 2019 to adopt the RSA.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
HEALTH
INSURANCE INNOVATIONS, INC.
|
|
|
|
|
By:
|
/s/
Michael D. Hershberger
|
|
Name:
|
Michael D. Hershberger
|
|
Title:
|
Chief Financial Officer
|
|
|
|
Date: February 4, 2019
|
|
|
Health Insurance Innovat... (NASDAQ:HIIQ)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Health Insurance Innovat... (NASDAQ:HIIQ)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024
Notícias em tempo-real sobre Health Insurance Innovations Inc da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Health Insurance Innovations, Inc.